It’s a good time to buy stocks for a patient investor, said S Naren, ED and CIO of ICICI Prudential AMC, on Monday, adding that “pharma looks reasonably valued at this point in time.”

“Technology is priced for growth and FMCG has always been priced for growth even if it doesn’t deliver growth. So pharma and utilities are the two sectors which look reasonably valued at this point in time,” he said.

Also Read: Hotel, restaurant stocks under selling pressure amid fresh COVID-19 restrictions over Omicron

Naren further said that he is not too worried about growth for now. “Yes, near-term there is a problem of growth in many sectors and there has been a problem, but when you have so many IPOs getting traded on 2027 earnings – I do not worry about investing in stocks where the current growth is bad, but eventually growth will pick up,” said Naren.

For the entire interview, watch the video